Within the framework of the share buyback program which was announced in the press release of March 10, 2021, Agfa-Gevaert NV proceeded with the purchase of own shares on the market of Euronext Brussels.

The authorization to acquire own shares was granted to the Board of Directors by the Extraordinary General Meeting of Shareholders of May 12, 2020.

Agfa-Gevaert NV has requested a financial intermediary to repurchase Agfa-Gevaert shares for a maximum amount of 50,000,000 Euro on its behalf under the terms of an initial discretionary mandate agreement with validity until March 31, 2022, effective as from April 1, 2021.

As a result of a decision of the Board of Directors, the company, by notarial deed dated December 28, 2021, cancelled a total of 2,288,302 treasury shares. This decision was taken in accordance with the authorization granted to the Board of Directors by the Extraordinary General Meeting of Shareholders on May 12, 2020. As a consequence, the new number of outstanding shares (denominator) is 160,506,706.

On December 31, 2021, the Agfa-Gevaert Group held 128,658 own shares, which represents 0.08% of the total number of shares of the Group.

Detailed operations per day:

Date Number of
shares
Average
price (€)
Minimum
price (€)
Maximum
price (€)
Total
price (€)
December 27, 2021 22,663 3.7193 3.6950 3.7350 84,290.50
December 28, 2021 30,336 3.7670 3.7350 3.7850 114,275.71
December 29, 2021 37,717 3.7670 3.7500 3.7800 142,079.94
December 30, 2021 27,072 3.7710 3.7400 3.7900 102,088.51
December 31, 2021 33,533 3.7881 3.7800 3.7900 127,026.36
Total 151,321 3.7652 569,761.02

Since the beginning of the share buyback program until December 31th, 2021; the Agfa-Gevaert Group bought 7,373,142 own shares, representing 4.40% of the total outstanding shares on April 1, 2021.

About Agfa

The Agfa-Gevaert Group is a leading company in imaging technology and IT solutions with over 150 years of experience. The Group holds four divisions: Radiology Solutions, HealthCare IT, Digital Print & Chemicals and Offset Solutions. They develop, manufacture and market analogue and digital systems for the healthcare sector, for specific industrial applications and for the printing industry. In 2020, the Group realized a turnover of 1,709 million Euro.

Contact:

Viviane Dictus
Director Corporate Communication
T +32 (0) 3 444 71 24
E viviane.dictus@agfa.com

Johan Jacobs
Corporate Press Relations Manager
T +32 (0)3/444 80 15
E johan.jacobs@agfa.com